Publisher
Springer International Publishing
Reference6 articles.
1. Ballaux, F., Debiec-Rychter, M., De Wever, I., & Sciot, R. (2004). Chondroid lipoma is characterized by t(11;16)(q13;p12–13). Virchows Archiv, 444(2), 208–210.
2. Flucke, U., Tops, B. B., de Saint Aubain Somerhausen, N., Bras, J., Creytens, D. H., Küsters, B., Groenen, P. J., Verdijk, M. A., Suurmeijer, A. J., & Mentzel, T. (2013). Presence of C11orf95-MKL2 fusion is a consistent finding in chondroid lipomas: a study of eight cases. Histopathology, 62, 925–930.
3. Gisselsson, D., Domanski, H. A., Höglund, M., Carlén, B., Mertens, F., Willén, H., & Mandahl, N. (1999). Unique cytological features and chromosome aberrations in chondroid lipoma: A case report based on fine-needle aspiration cytology, histopathology, electron microscopy, chromosome banding, and molecular cytogenetics. The American Journal of Surgical Pathology, 23, 1300–1304.
4. Huang, D., Sumegi, J., Dal Cin, P., Reith, J. D., Yasuda, T., Nelson, M., Muirhead, D., & Bridge, J. A. (2010). C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma. Genes, Chromosomes & Cancer, 49, 810–818.
5. Meis, J. M., & Enzinger, F. M. (1993). Chondroid lipoma: a unique tumor simulating liposarcoma and myxoid chondrosarcoma. The American Journal of Surgical Pathology, 17, 1103–1112.